8-Methyl-1,4-dioxaspiro[4.5]decan-8-amine, 95%, 250mg

2-(2H-1,2,3-TRIAZOL-2-YL)BENZOIC ACID, 95.0%, 10g

(1R,2R)-N,N'-DIMETHYL-1,2-DIPHENYL-1,2-ETHANEDIAMINE, 97.0%, 5g

6-methyl-4-(m-tolyl)-5-(3-(p-tolyl)-1,2,4-oxadiazol-5-yl)-3,4-dihydropyrimidine-2(1H)-thione, 95.0%, 1g

Oxazol-2-ylamine, 98.0%, 100g

[(2-ethyl-1,3-thiazol-4-yl)methyl]amine dihydrochloride hydrate, 95.0%, 10g

(S)-Glycidoxy-t-butyldimethylsilane, >95.0%(GC), 1g

(5-Cyclopropyloxazol-4-yl)methanamine hydrochloride, 97%, 100mg

1-(3-(Dimethylphosphoryl)phenyl)ethanone, 98%, 1g

2,5-Dimethylhex-3-ene-2,5-diol, 95.0%, 100g

anti-phosphatase alcaline (intestinale) monoclonal de souris, V17.1

Odanacatib, 99.82%, 5mg

7-Bromo-2H-benzo[b][1,4]thiazin-3(4H)-one, 95.0%, 1g